Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience
Crossref DOI link: https://doi.org/10.1007/s40264-018-0745-0
Published Online: 2018-10-17
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Marcinak, John F. http://orcid.org/0000-0002-9408-1889
Munsaka, Melvin S.
Watkins, Paul B.
Ohira, Takashi
Smith, Neila
Text and Data Mining valid from 2018-10-17
Article History
First Online: 17 October 2018